Paradromics podcast - biologists, engineers, and lawyers

Welcome to the Neurotech Pub! During last week’s world premiere of Paradromics’ new podcast at SynBioBeta 2020, host and Paradromics CEO Matt Angle spoke with Tim Harris, Cindy Chestek, and Philip “Flip” Sabes about the big programmatic challenges in neurotechnology. In this episode they discuss the differences between labs, startups, and large research consortia, as well as the difference between neuroscience and neuroengineering. Tim explains how one of the biggest breakthroughs in neurophysiology was the product of….lawyers. If you’d like to take a deep dive into the topics discussed, click the embedded links in the video or check out the show notes below. 2:04 | Jester King Brewery, Dripping Springs, TX | 3:03 | Bell Labs | 7:31 | Michael Jordan | 9:05 | Krishna Shenoy & Reid Harrison | 9:49 | Stevenson’s Law | 12:10 | Utah Array | 13:43 | Neuropixels | 14:06 | Dendrites by Nelson Sprusten, Greg Stuart, & Michael Häusser | 24:47 | Low-power neural signal processing by Chestek Lab |

Welcome to the Neurotech Pub! During last week’s world premiere of Paradromics’ new podcast at SynBioBeta 2020, host and Paradromics CEO Matt Angle spoke with Tim Harris, Cindy Chestek, and Philip “Flip” Sabes about the big programmatic challenges in neurotechnology. In this episode they discuss the differences between labs, startups, and large research consortia, as well as the difference between neuroscience and neuroengineering. Tim explains how one of the biggest breakthroughs in neurophysiology was the product of….lawyers. If you’d like to take a deep dive into the topics discussed, click